---
schema_version: "secwatch.filing_event.v1"
accession: "0001459839-21-000051"
form_type: "8-K"
ticker: "SIBN"
cik: "0001459839"
company_name: "SI-BONE, Inc."
filed_at: "2021-08-02T23:59:59+00:00"
generated_at: "2026-06-29T23:52:41.110491+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SI-BONE posts record Q2 revenue of $22.2M, gets exclusive Anthem coverage

## Summary
- Record Q2 worldwide revenue $22.2M (+58% YoY); U.S. revenue $20.2M (+53%).
- Exclusive coverage from Anthem (40M+ members) expands SI joint fusion access; also positive Centene coverage.
- Gross margin 89%; guidance raised to 87-89%; FY2021 revenue guidance maintained $92-94M.
- Net loss $14.0M ($0.42/sh) vs $12.5M ($0.44/sh) prior year; operating loss $13.0M.
- Published 2-year clinical trial results for iFuse-3D Implant System, 95th peer-reviewed publication.

## SEC filing metadata
- accession: 0001459839-21-000051
- form_type: 8-K
- ticker: SIBN
- cik: 0001459839
- company_name: SI-BONE, Inc.
- filed_at: 2021-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1459839/000145983921000051/0001459839-21-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1459839/000145983921000051/sibn-20210802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001459839-21-000051
- JSON: https://secwatch.observer/filing/0001459839-21-000051.json
- Plain text: https://secwatch.observer/filing/0001459839-21-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.